The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.
The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.
The pharmaceutical analysis firm is continuing its contract analytical laboratory services running, with changes designed to keep people and products safe.
Over the past week, the agency has issued guidances, taken action to accelerate treatments and put a stop to fraudulent treatments for the pandemic-causing virus.
The EndPandemic National Data Consortium has grown to six life-sciences and information-technology organizations, joining to collaborate on research data.
The health technology company is offering decentralized solutions enabling clinical trials for respiratory treatments to continue at participants’ homes.
Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.
TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pandemic with drug developments.
Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.
A report by Science 37 examines key considerations for patient safety and business continuity in the clinical trial industry in light of the ongoing coronavirus pandemic.
Apprentice is sending sets of technology tools to pharmaceutical research and manufacturing facilities, including its Tandem AR collaboration platform.
